Beta spectrin staining is associated with higher risk of recurrent disease in oral tongue squamous cell carcinoma (OTSCC)

•An aggressiveness biomarker for oral cancer has not yet been identified.•The protein beta-spectrin was identified as a possible biomarker candidate.•Increased numbers of tumor-infiltrated skeletal muscle cells expressing beta-spectrin are associated with decreased disease-free survival.